Finanzen von SunLink Health Systems Inc (SSY)SSYSunLink Health Systems Inc

SunLink Health Systems Inc (SSY) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy, accounting for 71.0% of total sales, equivalent to $7.80M. Another important revenue stream is Healthcare Services. Understanding this composition is critical for investors evaluating how SSY navigates market cycles within the Drug Retailers industry.

Evaluating the bottom line, SunLink Health Systems Inc maintains a gross margin of 37.83%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -9.33%, while the net margin is -8.60%. These profitability ratios, combined with a Return on Equity (ROE) of -22.34%, provide a clear picture of how effectively SSY converts its operational activities into shareholder value.

In the context of the broader market, SSY competes directly with industry leaders such as BTMD and VMD. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SSY's gross margin of 37.83% stands against BTMD's 65.38% and VMD's 57.19%. Such benchmarking helps identify whether SunLink Health Systems Inc is trading at a premium or discount relative to its financial performance.